Revvity Stock Deep Dive: Assessing Post Spin-Off Margins Against High Growth Competitors
Revvity is trying to prove the post-spin model can protect margins while faster life-science competitors chase growth.
OpenSearch
Find research, discussions, posts, companies, and topics.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
614Results20Tickers
Refine results
Recent Searches
Signed-in searches appear here after you use search.
Trending
XORTX Therapeutics Inc.: the filing proof gates that matter nowWilliams Companies: natural-gas infrastructure cash flow has to outlast capex and rate riskAurora Cannabis (ACB): the medical-cannabis turnaround trying to outrun dilutionAbbVie Inc. (ABBV) Coverage Bootstrap: Skyrizi and Rinvoq-led biopharma transition after HumiraAmbev (ABEV) Coverage Bootstrap: beer-led scale, Brazil execution, pricing discipline, and cash returnsAsbury Automotive Group (ABG) Coverage Bootstrap: dealership scale, service profit, F&I scrutiny, and leverage disciplineAble View Global (ABLV) Coverage Bootstrap: China beauty brand management, channel concentration, controlled voting, and listing riskABM Industries (ABM) Coverage Bootstrap: facility services scale, margin recovery, WGNSTAR integration, and labor execution
Top Tickers
Popular Tags
Tag facets appear after tag usage counts are rebuilt.
Results
Save searchLatest indexed results
Showing public results only.
ZETA: The growth headline is strong. The proof gate is quality, cash, and durability.
Zeta reported 50% Q1 revenue growth, raised 2026 guidance again, and launched Athena by Zeta. The proof gate is organic growth, super-scaled customers, adjusted EBITDA margin, and free cash flow.
OpenIONQ: Revenue is scaling, but the quantum proof gate is conversion plus losses.
Q1 2026 revenue beat, raised revenue guidance, and the first sixth-generation 256-qubit system sale. The proof gate is RPO conversion, organic revenue growth, and adjusted EBITDA loss discipline.
OpenVertiv Holdings: The Unsung Infrastructure Giant Cooling The Massive AI Data Center
AI data centers need power and cooling before they need another software demo.
OpenRDW Stock: The $498M Backlog Wall Street Cannot Ignore
Redwire has fresh space and drone headlines, but the real RDW proof gate is whether record backlog converts into profitable revenue and cash without new dilution pressure.
OpenNuScale Power Update: Evaluating Small Modular Reactors Against Increasing Data Center Demand
Small modular reactors sound like a data-center power answer, but NuScale still has to prove commercialization.
OpenThermo Fisher Capital Allocation: Does Their Services Ecosystem Outperform Agilent CrossLab Strategy?
Thermo Fisher and Agilent both use service ecosystems, but capital allocation decides which model compounds better.
OpenQBTS Stock: $100M Quantum CHIPS Shot, But Revenue Is Still Tiny
D-Wave has one of the clearest customer-demand signals in quantum after record bookings, but the Q1 revenue base remained small and losses expanded.
OpenJoby Aviation: Analyzing Certification Milestones Against Short Seller Liquidity Drain Risks
Joby needs certification progress to arrive before liquidity concerns dominate the air-taxi story.
OpenJoby Aviation Analysis: Measuring The Financial Runway Toward A Scalable Air Taxi Network
Joby has an ambitious air-taxi network vision, but the financial runway comes before scale.
OpenIonQ Stock: Exploring The Competitive Moat Against Tech Giants In Quantum Computing
IonQ needs to prove its quantum advantage can survive competition from larger tech platforms with deeper budgets.
OpenIonQ Quantum Analysis: Separating Academic Hype From Real World Commercial Revenue Streams
IonQ benefits from quantum-computing excitement, but investors need to separate scientific progress from commercial revenue.
OpenINFQ Stock: $100M Quantum Boost, But Can Infleqtion Scale Revenue?
Infleqtion has a clean quantum identity, record Q1 revenue, and a proposed $100M federal tailwind, but the business still needs revenue scale and operating-loss discipline.
OpenHims and Hers Health: Decoding The Business Model Pivot Toward GLP-1 Weight Loss
Hims is using GLP-1 weight loss to expand the platform, but the quality test is retention and cash flow.
OpenCoherent Corp Analysis: Tracking Laser Technology Adoption Within Next Generation Optical Networking
Coherent sits in lasers, optics, and networking components that matter as data traffic explodes.
OpenGinkgo Bioworks Pivot: Analyzing Synthetic Biology Profitability Shifts Toward Biosecurity Service Contracts
Ginkgo has moved from broad synthetic-biology promise toward a harder profitability test.
OpenDanaher Vs Agilent: Which Life Science Giant Wins The Recurring Revenue War?
Danaher and Agilent both sell into durable lab workflows, but the winner depends on recurring mix, margin quality, and cash conversion.
OpenBMNR Stock: The 9.5% ETH Toll Wall Street Cannot Ignore
BitMine priced an upsized preferred-stock deal, and the real question is whether ETH treasury growth can beat a new preferred dividend claim that sits ahead of common shareholders.
OpenBMNR: Ethereum treasury scale is huge. The proof is NAV, staking yield, and volatility control.
BMNR said crypto plus cash plus other holdings totaled twelve point three billion dollars as of May 25, 2026. The proof gate is ETH per share, staking yield, cash runway, and NAV transparency.
OpenBio-Rad Laboratories: Is The Clinical Diagnostics Segment Underpriced Relative To Growth Peers?
Bio-Rad has diagnostics exposure, but the market may be questioning whether the segment deserves a peer-growth multiple.
Open